INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS CITE FILES APPLICATION FOR "USE OF JAK INHIBITORS FOR ENHANCING THE POTENCY OF IMMUNOTHERAPY IN THE TREAMENT OF CANCER"

GENEVA, May 10 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) (55 boulevard Diderot,75012 Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3, Rue Michel Ange75016 Paris), UNIVERSITE PARIS CITE (85 Boulevard Saint-Germain,75006 Paris) filed a patent application (PCT/EP2025/081365) for "USE OF JAK INHIBITORS FOR ENHANCING THE POTENCY OF IMMUNOTHERAPY IN THE TREAMENT OF CANCER" on Oct 30, 2025. With publication no. WO/2026/093435, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World I...